
Abstract Objectives To assess the characteristics and outcomes in patients with Pulmonary Hypertension (PH) associated with Antisynthetase syndrome (ASyS). Methods Data for 88 ASyS patients assessed between 2000 and 2022 were obtained from the ASPIRE (Assessing the Spectrum of PH identified at a Referral centre) registry. Patients with pre-capillary PH were matched for age, sex and severity of PH with systemic sclerosis controls on a 1:1 basis. Results 64 patients had pre-capillary PH, 9 PH associated with left heart disease and 15 had no/unclassified-PH. Jo-1 was the most common antibody and was present more frequently in pre-capillary PH. Most patients had interstitial lung disease; nonspecific interstitial pneumonia was most common. Jo-1 antibodies were associated with an increased risk of PH and of more severe lung disease. Patients with pre-capillary PH had significantly worse spirometry, diffusing capacity of the lungs for carbon monoxide (DLco) and a trend towards more extensive interstitial lung disease than patients with no/unclassified-PH. In patients with ASyS-PH, higher age and increased pulmonary vascular resistance were independent predictors of mortality. 10-year survival was significantly worse in patients with pre-capillary PH than no/unclassified-PH. Despite less favourable spirometry, 10-year survival was significantly better in ASyS-PH than in systemic sclerosis-associated PH. Conclusion Most patients with ASyS-PH have parenchymal lung disease. Age and pulmonary vascular resistance are important prognostic predictors. Survival in ASyS-PH is superior to that of systemic sclerosis-associated pre-capillary PH.
To assess clinical and laboratory predictors of 10-year radiographic joint damage in contemporary recent-onset rheumatoid arthritis (RA). The study is a prospective multicentre cohort with 10-year follow-up, including 160 patients with recent-onset RA 2006-2009 throughout the southern half of Sweden. X-ray images of hands, wrists and feet from baseline and follow-up were scored according to the Larsen method. Baseline laboratory and clinical data was related to 10-year progression of radiographic joint damage by linear regression analyses. Median Larsen score at baseline was 1.0 (IQR: 0.0 to 4.0), and 8.0 (IQR: 3.0 to 13) after 10 years, with a median progression of 5.0 (IQR: 1.3 to 9.8). In univariable analyses, higher 28-joint disease activity score (DAS28) at baseline, DAS28 at 6 months and age were associated with increased progression of Larsen score. In multivariable analyses, statistical significance remained for high disease activity (DAS28>5.1) at baseline (regression coefficient 0.27 p = 0.038). Anti-citrullinated protein antibodies and rheumatoid factor were not associated with progression of total Larsen score. Radiographic damage after 10 years with RA was considerably lower in this study compared to historical cohorts with 10-year follow-up. Baseline disease activity remains an independent predictor of 10-year radiographic progression. Therefore, the initial presentation of the RA patient needs to be considered also in the long-term management. Since long-term radiographic damage is only partly explained by DAS28, our study highlights the need for additional prognostic tools to individualize therapeutic decisions.
Abstract Objectives We explored health-related quality of life (HRQoL) in relation to fatigue, depression, anxiety, and disease characteristics in people with ANCA-associated vasculitis (AAV) and Systemic Lupus Erythematosus (SLE). Methods In this cross-sectional study, patient-reported outcome measures included HRQoL (EQ-5D-3L), fatigue (Multidimensional Assessment of Fatigue), and anxiety and depression (Hospital Anxiety and Depression Scale). Physicians assessed disease activity and characteristics. Group comparisons used chi-square and Mann–Whitney U tests. Multivariable linear regression models identified determinants of HRQoL. Results We included 481 individuals with SLE, 256 with AAV, and 125 controls. Individuals with AAV and SLE experienced reduced HRQoL, greater fatigue, and higher levels of anxiety and depression compared to controls, but no differences were found between SLE and AAV. In combined SLE/AAV analyses, active organ involvement (skin, lungs, kidneys), was associated with lower HRQoL and more fatigue. In linear regression, including physical, social, and disease-specific aspects (Model A), active disease and older age were associated with lower HRQoL, while being male and cohabitation were associated with higher HRQoL. The adjusted R² value indicated that Model A explained 12.1% of the variance in HRQoL. After adding psychological aspects, fatigue, depression, and anxiety (Model B), the adjusted R² value indicated that the model explained 35.9% of the variance, increasing the proportion of HRQoL variance explained. Conclusion Across SLE and AAV diagnoses, active organ involvement in skin, lungs and kidneys was associated with lower HRQoL and more fatigue. Furthermore, combining disease characteristics with psychological aspects increased the explanatory determinants of HRQoL in both diseases.